These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 20065131

  • 1. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ.
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [Abstract] [Full Text] [Related]

  • 2. Minimal clinically important change on the unified Parkinson's disease rating scale.
    Schrag A, Sampaio C, Counsell N, Poewe W.
    Mov Disord; 2006 Aug; 21(8):1200-7. PubMed ID: 16673410
    [Abstract] [Full Text] [Related]

  • 3. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB.
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [Abstract] [Full Text] [Related]

  • 4. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT, Goetz CG.
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [Abstract] [Full Text] [Related]

  • 5. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 6. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E, Franchignoni F, Pasetti C, Ferriero G, Picco D.
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [Abstract] [Full Text] [Related]

  • 7. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, Wenning GK.
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [Abstract] [Full Text] [Related]

  • 8. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH, Chung SJ, Kim SR, Lee MC.
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [Abstract] [Full Text] [Related]

  • 9. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J, Fisher BE, Petzinger G, Wu A, Gordon J, Salem GJ.
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [Abstract] [Full Text] [Related]

  • 10. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
    Martinez-Martin P, Forjaz MJ.
    Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
    [Abstract] [Full Text] [Related]

  • 11. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.
    Neurology; 2005 Nov 08; 65(9):1436-41. PubMed ID: 16275832
    [Abstract] [Full Text] [Related]

  • 12. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
    Louis ED, Lynch T, Marder K, Fahn S.
    Mov Disord; 1996 Mar 08; 11(2):185-92. PubMed ID: 8684390
    [Abstract] [Full Text] [Related]

  • 13. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA, Grosset DG.
    Mov Disord; 2005 May 08; 20(5):616-9. PubMed ID: 15719417
    [Abstract] [Full Text] [Related]

  • 14. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
    Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ.
    Mov Disord; 2002 Sep 08; 17(5):867-76. PubMed ID: 12360535
    [Abstract] [Full Text] [Related]

  • 15. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, Kaito M, Higashi K, Taki S, Kakeshita K, Fujino S, Miaki M.
    J Neurol Sci; 2004 May 15; 220(1-2):105-11. PubMed ID: 15140615
    [Abstract] [Full Text] [Related]

  • 16. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, Parkinson Study Group.
    Mov Disord; 2002 Jul 15; 17(4):758-63. PubMed ID: 12210871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.